Thursday, February 14, 2019 9:48:53 AM
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it will report its financial results for the fourth quarter ended December 31, 2018, on Thursday, February 28, after the markets close. Foamix will host a conference call and webcast at 8:30 a.m. Eastern Time on Friday, March 1.
Conference Call & Webcast Friday, March 1st @ 8:30am Eastern Time Toll Free: 877-407-0784 International: 201-689-8560 Conference ID: 13687390 Webcast: http://public.viavid.com/index.php?id=133210 Replays, Available through March 15th: Toll-Free: 844-512-2921 Internation al: 412-317-6671 Conference ID: 13687390 A replay will also be archived on the Company's website at www.foamix.com promptly after the conference call.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM